RPGK
VRTX icon

Retirement Planning Group (Kansas)’s Vertex Pharmaceuticals VRTX Stock Holding History

Retirement Planning Group (Kansas)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
970
-33
-3% -$14.6K 0.01% 335
2026
Q1 		$448K Buy
1,003
+533
+113% +$249K 0.01% 321
2025
Q4 		$213K Buy
+470
New +$203K 0.01% 404
2025
Q2 		– Sell
-450
Closed -$218K – 319
2025
Q1 		$218K Buy
+450
New +$210K 0.01% 283

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Retirement Planning Group (Kansas)'s VRTX Position: Q2 2026 in Review

Retirement Planning Group (Kansas) reduced its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q2 2026, selling an estimated $14.6K and leaving 970 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #335.

Retirement Planning Group (Kansas) first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Retirement Planning Group (Kansas) held 970 shares of Vertex Pharmaceuticals worth $482K as of Q2 2026.
  • Retirement Planning Group (Kansas) sold 33 Vertex Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
  • Vertex Pharmaceuticals made up 0.01% of Retirement Planning Group (Kansas)'s portfolio in Q2 2026, its #335 holding.
  • Retirement Planning Group (Kansas) first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Retirement Planning Group (Kansas)'s 13F filing for Q2 2026, filed 5 Aug 2026.